Bank of New York Mellon’s CASI Pharmaceuticals CASI Stock Holding History

Bank of New York Mellon’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,644	Closed	-$29K	–	4598
2022 Q1	$29K	Hold	3,644	–	–	﹤0.01%	4592
2021 Q4	$29K	Hold	3,644	–	–	﹤0.01%	4557
2021 Q3	$43K	Hold	3,644	–	–	﹤0.01%	4451
2021 Q2	$56K	Sell	3,644 -15,141	-81%	-$255K	﹤0.01%	4310
2021 Q1	$451K	Buy	18,785 +17	+0.1%	+$477	﹤0.01%	3744
2020 Q4	$554K	Buy	18,768 +1,203	+7%	+$26.1K	﹤0.01%	3565
2020 Q3	$268K	Buy	17,565 +101	+0.6%	+$1.9K	﹤0.01%	3757
2020 Q2	$436K	Buy	17,464 +678	+4%	+$14.7K	﹤0.01%	3545
2020 Q1	$343K	Buy	16,786 +817	+5%	+$19.5K	﹤0.01%	3541
2019 Q4	$493K	Sell	15,969 -377	-2%	-$12.2K	﹤0.01%	3601
2019 Q3	$545K	Sell	16,346 -447	-3%	-$14.3K	﹤0.01%	3489
2019 Q2	$537K	Sell	16,793 -251	-1%	-$8.01K	﹤0.01%	3561
2019 Q1	$489K	Sell	17,044 -251	-1%	-$8.75K	﹤0.01%	3565
2018 Q4	$695K	Buy	17,295 +1,978	+13%	+$74.9K	﹤0.01%	3306
2018 Q3	$715K	Buy	15,317 +1,705	+13%	+$119K	﹤0.01%	3454
2018 Q2	$1.12M	Buy	13,612 +9,924	+269%	+$670K	﹤0.01%	3191
2018 Q1	$154K	Buy	+3,688	New	+$138K	﹤0.01%	3982

Other funds holding CASI

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon's CASI Position: Q2 2022 in Review

Bank of New York Mellon sold out of CASI Pharmaceuticals (CASI) in Q2 2022, closing a stake of 3,644 shares — an estimated $29K sold.

Bank of New York Mellon first reported a position in CASI in Q1 2018 and held it in 17 quarters. The position peaked at $1.12M in Q2 2018. 24 funds tracked by Wall St. Rank hold CASI as of Q2 2022.

Bank of New York Mellon reported no remaining CASI Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Bank of New York Mellon sold 3,644 CASI Pharmaceuticals shares in Q2 2022, an estimated $29K.
Bank of New York Mellon first reported a position in CASI Pharmaceuticals in Q1 2018 and held it in 17 quarters.
Bank of New York Mellon's CASI Pharmaceuticals position peaked at $1.12M in Q2 2018.
24 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2022.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.